Dr. Fidelholtz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6103 Hamilton Ave
# 45224
Cincinnati, OH 45224Phone+1 513-681-6667Fax+1 513-681-0252
Education & Training
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1973 - 1976- Mount Sinai Medical Center of ClevelandInternship, Transitional Year, 1972 - 1973
University of Cincinnati College of MedicineClass of 1972
Certifications & Licensure
OH State Medical License 1972 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females Start of enrollment: 2007 Oct 01
- A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Start of enrollment: 2014 Feb 01
- 12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 26 citationsSafety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms.James Fidelholtz, William Smith, James Rawls, Yingqi Shi, Anna Zack
The American Journal of Gastroenterology. 2002-05-01 - 4 citationsIntractable Ascites: Surgical Management With Reduction in Secondary HyperaldosteronismJames E. Sampliner, Saul M. Genuth, James Fidelholtz, Norman J. Kozokoff
JAMA. 1976-08-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
